Cases & Deals

Athersys completes $23 million public offering of Common Stock

Clients Athersys, Inc.

Jones Day represented Athersys, Inc., an international biotechnology company developing novel and proprietary best-in-class therapies designed to extend and enhance the quality of human life, in connection with its public offering of 22,772,300 shares of Common Stock. William Blair & Company, L.L.C. acted as sole book-running manager and Needham & Company, LLC acted as lead manager for the offering.

We use cookies to deliver our online services. Details of the cookies and other tracking technologies we use and instructions on how to disable them are set out in our Cookies Policy. By using this website you consent to our use of cookies.